Format

Send to

Choose Destination
Diabetes Care. 2019 Feb;42(2):e21-e23. doi: 10.2337/dc18-1893. Epub 2018 Dec 7.

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System.

Author information

1
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC tianwang@unc.edu.
2
Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing, China.
3
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
4
Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
5
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
6
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
PMID:
30530488
PMCID:
PMC6341287
[Available on 2020-02-01]
DOI:
10.2337/dc18-1893

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center